 |
 |
| 序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
| 1 | 毕得医药 | 501.98 | 未变 | 流通A股 | 5.52% | 2025-03-31 |
| 2 | 毕得医药 | 501.98 | 未变 | 流通A股 | 5.52% | 2025-02-17 |
| 3 | 毕得医药 | 501.98 | 未变 | 流通A股 | 5.52% | 2025-01-13 |
| 4 | 毕得医药 | 501.98 | 未变 | 流通A股 | 5.52% | 2024-12-31 |
| 5 | 毕得医药 | 501.98 | 未变 | 流通A股 | 5.52% | 2024-09-30 |
| 6 | 毕得医药 | 501.98 | 未变 | 流通A股 | 5.52% | 2024-06-30 |
| 7 | 毕得医药 | 501.98 | 未变 | 流通A股 | 5.52% | 2024-06-27 |
| 8 | 毕得医药 | 501.98 | 新进 | 流通A股 | 5.52% | 2024-03-31 |
| 序号 | 股票 | 持股数量(万股) | 持股变动 | 股份性质 | 占总股本比例 | 报告期 |
| 1 | 毕得医药 | 501.98 | 未变 | 境内法人股 | 11.611% | 2025-03-31 |
| 2 | 毕得医药 | 501.98 | 未变 | 境内法人股 | 11.611% | 2025-02-17 |
| 3 | 毕得医药 | 501.98 | 未变 | 境内法人股 | 11.611% | 2025-01-13 |
| 4 | 毕得医药 | 501.98 | 未变 | 境内法人股 | 11.611% | 2024-12-31 |
| 5 | 毕得医药 | 501.98 | 未变 | 境内法人股 | 11.86% | 2024-09-30 |
| 6 | 毕得医药 | 501.98 | 未变 | 境内法人股 | 11.86% | 2024-06-30 |
| 7 | 毕得医药 | 501.98 | 新进 | 境内法人股 | 11.797% | 2024-03-31 |
|
|